On Oct. 27, 2010, the Advisory Committee on Immunization Practices (ACIP) approved updated recommendations for the use of quadrivalent (serogroup A, C, Y, and W-135) meningococcal conjugated vaccines (Menveo®, Novartis; and Menactra®, Sanofi Pasteur) for adolescents and persons with high risk for meningococcal disease.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content